September 10, 2017

Conversations with Federal HIV Leaders from the 2017 U.S. Conference on AIDS [video]

This article originally appeared on

First we heard from Dr. Anthony Fauci, Director of NIH’s National Institute of Allergies and Infectious Diseases, who spoke with his colleague Anne Rancourt immediately following his plenary address to the conference about opportunities and challenges in ending the HIV pandemic. Research supported by the National Institutes of Health (NIH) continues to transform the landscape for HIV prevention, care, and treatment. Dr. Fauci discussed research-proven tools currently available including preventing HIV transmission with antiretroviral therapy resulting in a suppressed viral load as well as HIV pre-exposure prophylaxis (PrEP). Implementation gaps, he noted, are among the key challenges that still need to be addressed if we are to end the pandemic. He also observed that NIH-supported research into new tools such as long-acting PrEP in injectable or implantable forms and an HIV vaccine are among the possible routes to addressing some of those gaps in the future.

Read the full article>>